A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/12/2009	US20090281060 Heterocyclic derivatives as gpcr receptor agonists
11/12/2009	US20090281059 Coating for a medical device having an anti-thrombotic conjugate
11/12/2009	US20090281058 Compositions of partially deacetylated chitin derivatives
11/12/2009	US20090281057 Botanically Derived Composition and a Process Thereof
11/12/2009	US20090281056 Cationized Hyaluronic Acid
11/12/2009	US20090281055 Palatinose for enhancing dietary supplement and pharmaceutical delivery
11/12/2009	US20090281054 Compositions and methods comprising capuramycin analogues
11/12/2009	US20090281053 Novel crystalline form of lamivudine
11/12/2009	US20090281052 Indole Antiviral Compositions And Methods
11/12/2009	US20090281051 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
11/12/2009	US20090281050 Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides
11/12/2009	US20090281049 New use of ginsenoside compound-k in manufacturing medicaments
11/12/2009	US20090281048 Method and System for Inducing Anti-aging in Skin
11/12/2009	US20090281047 Use of benzaldehyde derivatives, precursors and intermediaries alone or in combination with additional therapeutic agents to stimulate the immune system and inhibit cellular proliferation; e.g. use of 6-0-benzylidine-D-glucopyranosyloxy
11/12/2009	US20090281046 Cyclopropanated Carbohydrates
11/12/2009	US20090281045 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
11/12/2009	US20090281043 Tumor antigen based on products of the tumor suppressor gene wt1
11/12/2009	US20090281040 Methods For Treating Endoplasmic Reticulum (ER) Stress Disorders
11/12/2009	US20090281039 Satiety inducing products and a method of their production
11/12/2009	US20090281030 Genes Associated with Macular Degeneration
11/12/2009	US20090281019 Compositions and methods for treating atrial fibrillation
11/12/2009	US20090280987 Method For Solubilising, Dispersing and Stabilising of Substances, Products Manufactured According To The Method As Well As The Use Thereof
11/12/2009	US20090280555 Enzyme treatment of foodstuffs for celiac sprue
11/12/2009	US20090280198 Combined effects of nutrients on proliferation of stem cells
11/12/2009	US20090280192 Method for treating or preventing alzheimer's disease
11/12/2009	US20090280189 System for the liberation of an active principle and its use
11/12/2009	US20090280188 Asymmetric functionalizated nanoparticles and methods of use
11/12/2009	US20090280184 Pharmaceutical composition, method of preparation and methods of treating aches/pains
11/12/2009	US20090280183 Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration
11/12/2009	US20090280181 Delivery of nucleic acid complexes from particles
11/12/2009	US20090280178 Process for the Preparation of Sevelamer Hydrochloride and Formulation Thereof
11/12/2009	US20090280177 Pharmaceutical preparation for treating fibromyalgia
11/12/2009	US20090280176 Controlled release formulations of alprazolam
11/12/2009	US20090280175 Multilayer Proton Pump Inhibitor Tablets
11/12/2009	US20090280174 Solid Pharmaceutical Preparation
11/12/2009	US20090280173 Multilayer Omeprazole Tablets
11/12/2009	US20090280172 Galenic formulations of organic compounds
11/12/2009	US20090280171 Method of treatment with predictably breakable pharmaceutical tablets
11/12/2009	US20090280168 Chlamydia polypeptides used to prevent, treat, and diagnose Chlamydia infection; 98 KDa OMP antigen designated CPN100686 RY 54
11/12/2009	US20090280167 Enhancement of drug therapy by mirna
11/12/2009	US20090280166 Ferritin as a therapeutic target in abnormal cells
11/12/2009	US20090280164 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
11/12/2009	US20090280163 High-Efficiency Fusogenic Vesicles, Methods of Producing Them, and Pharmaceutical Compositions Containing Them
11/12/2009	US20090280160 Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption
11/12/2009	US20090280158 Sustained release delivery of active agents to treat glaucoma and ocular hypertension
11/12/2009	US20090280153 electrical devices, anti-scarring agents, and therapeutic compositions
11/12/2009	US20090280148 Casein nanoparticle
11/12/2009	US20090280143 Genetic adjuvants for immunotherapy
11/12/2009	US20090280141 Streptococcal Genes
11/12/2009	US20090280133 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
11/12/2009	US20090280130 Method for the treatment of anthrax toxicity
11/12/2009	US20090280128 Anti-ilt7 antibody
11/12/2009	US20090280125 Prion epitopes and methods of use thereof
11/12/2009	US20090280123 comprising a nucleic acid sequence encoding a KIF18A polypeptide being expressed in mesenchymal stem cells; kinesins capable of binding estrogen receptors
11/12/2009	US20090280115 Dihydropteridinones in the Treatment of Respiratory Diseases
11/12/2009	US20090280112 Inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cells
11/12/2009	US20090280110 Cell Model for Alzheimer's Disease Pathology
11/12/2009	US20090280109 ILT3 and ILT4-related compositions and methods
11/12/2009	US20090280105 Novel Fungal Enzymes
11/12/2009	US20090280103 Regulation of muscle repair
11/12/2009	US20090280092 G-Protein Coupled Receptor 83 As a Molecular Switch for the Induction of Regulatory (immunosuppressive) T-cells
11/12/2009	US20090280088 Method of controlling hair shape
11/12/2009	US20090280086 Methods and compositions for treating hepatitis c virus
11/12/2009	US20090280084 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
11/12/2009	US20090280083 Compounds for the Treatment of Hepatitis C
11/12/2009	US20090280081 JAK/STAT pathway inhibitors and uses thereof
11/12/2009	US20090280069 Proguanil to treat skin/mucosal diseases
11/12/2009	US20090280068 Polymorph of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride
11/12/2009	US20090280067 Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride
11/12/2009	US20090280062 Longevity-promoting effects of acetic acid and reishi polysaccharide
11/12/2009	US20090280061 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
11/12/2009	US20090280059 Substituted aryl piperidinylalkynyladenosines as a2ar agonists
11/12/2009	DE102008022521A1 1,4-Diaryl-pyrimidopyridazin-2,5-dione und ihre Verwendung 1,4-diaryl-pyrimidopyridazin-2,5-diones and their use
11/12/2009	DE102008022520A1 Feste Arzneimittelformulierung mit verzögerter Freisetzung Solid pharmaceutical formulation with sustained release
11/12/2009	DE102008022221A1 Inhibitoren der humanen Aldosteronsynthase CYP11B2 Inhibitors of human aldosterone synthase CYP11B2
11/12/2009	DE102008009039B4 Neue Verbindungen aus Antrodia camphorata New compounds from Antrodia camphorata
11/12/2009	CA2755499A1 Protection of normal cells
11/12/2009	CA2728893A1 Inhibitors of syk protein kinase
11/12/2009	CA2728229A1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
11/12/2009	CA2728227A1 Therapeutic cyclopentane derivatives
11/12/2009	CA2726866A1 Methods and compositions for the treatment of huntington's disease
11/12/2009	CA2725546A1 Methods for preventing and treating neurodegenerative diseases
11/12/2009	CA2725209A1 Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
11/12/2009	CA2724972A1 Therapeutic compounds
11/12/2009	CA2723894A1 Therapeutic substituted hydantoins, and related compounds
11/12/2009	CA2723893A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009	CA2723798A1 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
11/12/2009	CA2723775A1 Therapeutically useful substituted 1,7-diphenyl-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline compounds
11/12/2009	CA2723751A1 Alpha2b and alpha2c agonists
11/12/2009	CA2723745A1 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
11/12/2009	CA2723744A1 Sialic acid to support salivation
11/12/2009	CA2723716A1 Enhancement of drug therapy by mirna
11/12/2009	CA2723704A1 Nitric oxide donating prostamides
11/12/2009	CA2723702A1 Preparation of intermediates useful in the synthesis of 2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosylcytosine
11/12/2009	CA2723688A1 Method for treating neurodegenerative dysfunction
11/12/2009	CA2723685A1 Oral administration of peripherally-acting opioid antagonists
11/12/2009	CA2723683A1 7h-indolo[2,1-a] [2] benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c
11/12/2009	CA2723679A1 Muscarinic receptor agonists useful in the treatment of pain, alzheimer's disease and schizophrenia
11/12/2009	CA2723600A1 Method for producing bicyclic guanidines by use of a cyclic urea
11/12/2009	CA2723590A1 Novel nitroso compounds as nitroxyl donors and methods of use thereof

1 ... 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 ... 7860